Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company leveraging a novel oligonucleotide promoted editing of RNA (OPERA ®) platform to develop a new class of genetic medicines for rare ...
Detailed price information for Proqr Therapeutics (PRQR-Q) from The Globe and Mail including charting and trades.
Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...
Detailed price information for Proqr Therapeutics (PRQR-Q) from The Globe and Mail including charting and trades.
ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a clinical-stage biotechnology company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer ™ RNA ...
RNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene ...
In a study published in Science Translational Medicine, a team of researchers led by Dr. Wang Yu from the Shenzhen Institutes ...
ARPA-H gene editing program THRIVE awards $160 million to seven research teams tasked with building scalable base-editing ...
CapCut, the mobile video editor from TikTok parent company ByteDance, is among the most popular such apps in the Apple App Store and Google Play Store, and for good reason. For a mobile app, CapCut is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results